|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2330 USD | +5.43% |
|
+8.07% | -53.21% |
| Market Cap | 12.66M 10.95M 10.23M 9.38M 17.65M 1.21B 17.93M 120M 47.1M 604M 47.55M 46.51M 2B | P/E 2026 * |
23.3x | P/E 2027 * | 3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 12.66M 10.95M 10.23M 9.38M 17.65M 1.21B 17.93M 120M 47.1M 604M 47.55M 46.51M 2B | EV / Sales 2026 * |
0.15x | EV / Sales 2027 * | 0.11x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +5.43% | ||
| 1 week | +8.07% | ||
| Current month | +8.07% | ||
| 1 month | -11.71% | ||
| 3 months | -29.88% | ||
| 6 months | -48.16% | ||
| Current year | -53.21% |
| 1 week | 0.21 |  | 0.25 |
| 1 month | 0.18 | | 0.35 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 2.05 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/30/26 A | Buy | Chief Executive Officer | 349,825 | 1.1578% | ||
| 7/29/26 A | Free | Chief Financial Officer | 328,407 | 1.0869% | ||
| 7/29/26 A | Buy | Chief Executive Officer | 766,284 | 2.5362% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.43% | +8.07% | -70.78% | -82.74% | 12.66M | |
| -0.21% | +1.56% | +30.06% | +103.30% | 101B | |
| -0.53% | +2.77% | +50.18% | +157.63% | 55.37B | |
| -0.33% | +1.36% | +4.20% | +277.22% | 24.21B | |
| +1.64% | -0.95% | -12.47% | -14.05% | 8.29B | |
| +4.21% | -0.41% | -31.74% | -26.33% | 7.53B | |
| -0.82% | -2.42% | -10.17% | -20.93% | 6.75B | |
| +0.14% | +0.19% | +19.28% | +12.93% | 6.19B | |
| -1.85% | -4.36% | -2.55% | +21.15% | 5.07B | |
| +0.81% | -3.11% | -6.73% | -8.23% | 3.69B | |
| Average | +0.85% | +0.49% | -3.07% | +41.99% | 21.85B | |
| Weighted average by Cap. | -0.11% | +1.38% | +25.62% | +117.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.3M 72.92M 68.1M 62.47M 117M 8.02B 119M 799M 314M 4.02B 317M 310M 13.29B | 111M 95.84M 89.5M 82.11M 154M 10.55B 157M 1.05B 412M 5.29B 416M 407M 17.47B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | $0.2330 | +5.43% | 5,742,937 |
| 06/08/26 | $0.2210 | +2.89% | 2,624,814 |
| 05/08/26 | $0.2148 | -4.11% | 1,887,964 |
| 04/08/26 | $0.2240 | -4.68% | 2,430,675 |
| 03/08/26 | $0.2350 | +9.00% | 5,876,103 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
